MACKAY MARTIN — SEC insider filings
SEC reporting owner CIK 1414815. 22 insider filings on record with FilingPulse; latest filed 2026-11-05.
Transaction summary — filings shown
Covers all 22 filings on record, filed 2020-10-20 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 10,000 shares, $103,473 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 46.
- Largest priced transaction: purchase of 5,504 shares @ $10.10 ($55,590) in Rallybio Corp, filed 2022-01-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rallybio Corp (RLYB) | Director | 8 | 2 legs · 10,000 sh · $103,473 | — | 20 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | 9 | — | — | 19 |
| SpringWorks Therapeutics, Inc. (SWTX) | Director | 3 | — | — | 5 |
| 5:01 Acquisition Corp. (FVAM) | Director | 1 | — | — | 1 |
| Kailera Therapeutics, Inc. (KLRA) | Director | 1 | — | — | 1 |
Insider filings — MACKAY MARTIN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-05 | 4 | Rallybio Corp (RLYB) | Option exercise (M): 11,607 @ $7.60 · Option exercise (M): 3,562 @ $2.38 · Option exercise (M): 18,055 @ $4.45 · Option exercise (M): 11,607 (derivative) @ $5.60 · Option exercise (M): 3,562 (derivative) @ $0 · Option exercise (M): 18,055 (derivative) @ $3.60 | EDGAR |
| 2026-05-11 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 1,438 @ $177.62 · Grant/award (A): 1,407 @ $177.62 | EDGAR |
| 2026-04-20 | 4 | Kailera Therapeutics, Inc. (KLRA) | Grant/award (A): 38,300 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 18,055 (derivative) @ $3.60 | EDGAR |
| 2025-07-02 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Disposition to issuer (D): 20,023 · Disposition to issuer (D): 29,445 (derivative) | EDGAR |
| 2025-05-23 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 946 @ $134.98 · Grant/award (A): 815 @ $134.98 · Grant/award (A): 2,076 (derivative) @ $134.98 | EDGAR |
| 2025-05-15 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 10,060 @ $0 | EDGAR |
| 2025-05-15 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 28,500 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 92,857 (derivative) @ $0.70 | EDGAR |
| 2024-07-30 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 9,963 @ $0 · Grant/award (A): 29,445 (derivative) @ $0 | EDGAR |
| 2024-05-15 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 559 @ $228.41 · Grant/award (A): 372 @ $228.41 · Grant/award (A): 1,311 (derivative) @ $228.41 | EDGAR |
| 2024-02-16 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 216,000 (derivative) @ $0 | EDGAR |
| 2023-07-05 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 95 @ $0 | EDGAR |
| 2023-06-02 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 338 @ $0 | EDGAR |
| 2023-05-17 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 664 @ $0 · Grant/award (A): 1,669 (derivative) @ $192.36 | EDGAR |
| 2023-02-06 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 214,000 (derivative) @ $0 | EDGAR |
| 2022-05-13 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 549 @ $0 · Grant/award (A): 292 @ $0 · Grant/award (A): 1,512 (derivative) @ $222.31 | EDGAR |
| 2022-02-09 | 4 | Rallybio Corp (RLYB) | Grant/award (A): 62,000 (derivative) @ $0 | EDGAR |
| 2022-01-12 | 4 | Rallybio Corp (RLYB) | Other (J): 272,609 · Other (J): 436,517 · Purchase (P): 5,504 @ $10.10 · Purchase (P): 4,496 @ $10.65 · Other (J): 2,255,001 (derivative) · Other (J): 2,564,999 (derivative) · +4 more | EDGAR |
| 2022-01-04 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 63 @ $0 | EDGAR |
| 2021-05-10 | 4 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Grant/award (A): 355 @ $0 · Grant/award (A): 219 @ $0 · Grant/award (A): 1,151 (derivative) @ $0 | EDGAR |
| 2020-10-20 | 4 | 5:01 Acquisition Corp. (FVAM) | Other (J): 30,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-19 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1414815 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs